课题基金 / 基金详情

MELATONIN, FREE RADICALS, IMMUNE FUNCTION AND AGING

MELATONIN, FREE RADICALS, IMMUNE FUNCTION AND AGING
褪黑激素、自由基、免疫功能和衰老
批准号:
2748566
负责人:
JAMES FLOYD NELSON
金额:
$20.11万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-15 至 2000-07-31

项目摘要

项目成果

JAMES FLOYD NELSON的其他基金

相似基金

相关文献

中文摘要
翻译
褪黑素延长寿命的能力是有争议的
英文摘要
DESCRIPTION: The ability of melatonin to prolong life is controversial and debatable. The evidence to support life prolongation are based on 1) serum melatonin falls progressively with age, 2) melatonin may be important in aging by virtue of its antioxidant and enhancement of immune function, and 3) two limited studies suggest that melatonin extends mean survival. A key goal of this application is to confirm or refute the initial observations and extend these findings in a laboratory having expertise in aging, antioxidant studies and immune functions. The three aims of this proposal are to determine if melatonin: 1) Prolongs life span and delays age related pathologies, 2) Reduces free radical generation, 3) Enhances immune competence. Male Fischer 344 rats will be given two doses (4 and 16 (g/ml) of melatonin. Controls will include ad libitum and calorically restricted animals (the most effective anti-aging method). Analysis will include mean life span as well as the delay of age-related pathologies. In separate studies, the effect of melatonin on oxidative stress and immune function will be examined. Together, these studies will indicate whether melatonin has broad anti-aging effects, including actions on antioxidant activity and immune function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
44th Annual Meeting of the American Aging Association
  • 批准号:
    8837925
  • 项目类别:
  • 资助金额:
    $4.67万
  • 财政年份:
    2015
  • 负责人:
    JAMES FLOYD NELSON
  • 依托单位:
Aging Aminal & Longevity Assessment Core
ANIMAL CORE
New Genetic Intervention for Healthy Aging
海外基金